467 related articles for article (PubMed ID: 29538454)
21. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry.
Hikosaka K; Noritake H; Kimura W; Sultana N; Sharkar MT; Tagawa Y; Uezato T; Kobayashi Y; Wakita T; Miura N
Biomed Res; 2011 Apr; 32(2):143-50. PubMed ID: 21551950
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
Sarhan MA; Chen AY; Michalak TI
PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
[TBL] [Abstract][Full Text] [Related]
23. Tandem overexpression of five human factors renders murine hepatocytes susceptible to hepatitis C virus.
Lv L; Kang Q; Yu X; Gao B; Hu T; Ma P; Zhang Y; Yan F; Xiao J; Deng J; Zhou X; Xu J
Acta Virol; 2015 Mar; 59(1):20-6. PubMed ID: 25790047
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells.
Sung PS; Murayama A; Kang W; Kim MS; Yoon SK; Fukasawa M; Kondoh M; Kim JS; Kim H; Kato T; Shin EC
J Virol; 2014 Aug; 88(16):9233-44. PubMed ID: 24899196
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C Virus Entry: Protein Interactions and Fusion Determinants Governing Productive Hepatocyte Invasion.
Gerold G; Moeller R; Pietschmann T
Cold Spring Harb Perspect Med; 2020 Feb; 10(2):. PubMed ID: 31427285
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of endogenous Claudin-1 expression, motility and susceptibility to hepatitis C virus in CRISPR knock-in cells.
Clément CMH; Deffieu MS; Dorobantu CM; Baumert TF; Ayala-Nunez NV; Mély Y; Ronde P; Gaudin R
Biol Cell; 2020 May; 112(5):140-151. PubMed ID: 32034780
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus receptor expression in normal and diseased liver tissue.
Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA
Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
[TBL] [Abstract][Full Text] [Related]
30. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT
J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
32. Effect of cell polarization on hepatitis C virus entry.
Mee CJ; Grove J; Harris HJ; Hu K; Balfe P; McKeating JA
J Virol; 2008 Jan; 82(1):461-70. PubMed ID: 17959672
[TBL] [Abstract][Full Text] [Related]
33. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
[TBL] [Abstract][Full Text] [Related]
34. Role of the cytosolic domain of occludin in trafficking and hepatitis C virus infection.
Lavie M; Linna L; Moustafa RI; Belouzard S; Fukasawa M; Dubuisson J
Traffic; 2019 Oct; 20(10):753-773. PubMed ID: 31328852
[TBL] [Abstract][Full Text] [Related]
35. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
36. Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.
Schwarz AK; Grove J; Hu K; Mee CJ; Balfe P; McKeating JA
J Virol; 2009 Dec; 83(23):12407-14. PubMed ID: 19776133
[TBL] [Abstract][Full Text] [Related]
37. How hepatitis C virus invades hepatocytes: the mystery of viral entry.
Zhu YZ; Qian XJ; Zhao P; Qi ZT
World J Gastroenterol; 2014 Apr; 20(13):3457-67. PubMed ID: 24707128
[TBL] [Abstract][Full Text] [Related]
38. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
[TBL] [Abstract][Full Text] [Related]
39. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.
Meyer K; Kwon YC; Liu S; Hagedorn CH; Ray RB; Ray R
Sci Rep; 2015 Mar; 5():9012. PubMed ID: 25757571
[TBL] [Abstract][Full Text] [Related]
40. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL
J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
